Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LIPG | Q9Y5X9 | 1/20 | 0.42 |
| ▸ | TP53 | P04637 | 3/20 | 0.41 |
| ▸ | CYP3A4 | P08684 | 3/20 | 0.41 |
| ▸ | TYR | P14679 | 2/20 | 0.41 |
| ▸ | ALOX15 | P16050 | 2/20 | 0.41 |
| ▸ | TSHR | P16473 | 2/20 | 0.41 |
| ▸ | MEN1 | O00255 | 1/20 | 0.41 |
| ▸ | ALOX5 | P09917 | 1/20 | 0.41 |
| ▸ | MAPT | P10636 | 1/20 | 0.41 |
| ▸ | HTT | P42858 | 1/20 | 0.41 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.41 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.41 |
| ▸ | CYSLTR2 | Q9NS75 | 2/20 | 0.38 |
| ▸ | CYSLTR1 | Q9Y271 | 2/20 | 0.38 |
| ▸ | GPR35 | Q9HC97 | 1/20 | 0.38 |
| ▸ | ESR1 | P03372 | 2/20 | 0.37 |
| ▸ | ADRA2A | P08913 | 2/20 | 0.37 |
| ▸ | ADORA3 | P0DMS8 | 2/20 | 0.37 |
| ▸ | TACR2 | P21452 | 2/20 | 0.37 |
| ▸ | SLC6A2 | P23975 | 2/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5170070 | 1.00 | LIPG (0.42) | LIPGTP53CYP3A4TYRALOX15 | |
| SCHEMBL20338197 | 1.00 | LIPG (0.42) | LIPGTP53CYP3A4TYRALOX15 | |
| SCHEMBL2145395 | 1.00 | LIPG (0.42) | LIPGTP53CYP3A4TYRALOX15 | |
| SCHEMBL5147986 | 1.00 | LIPG (0.42) | LIPGTP53CYP3A4TYRALOX15 | |
| SCHEMBL329220 | 1.00 | LIPG (0.42) | LIPGTP53CYP3A4TYRALOX15 | |
| SCHEMBL19304410 | 1.00 | LIPG (0.42) | LIPGTP53CYP3A4TYRALOX15 | |
| SCHEMBL1225175 | 1.00 | LIPG (0.42) | LIPGTP53CYP3A4TYRALOX15 | |
| SCHEMBL2795698 | 0.98 | LIPG (0.39) | LIPGTP53CYP3A4TYRALOX15 | |
| SCHEMBL4170722 | 0.92 | TYR (0.37) | LIPGTP53CYP3A4TYRALOX15 | |
| SCHEMBL28002435 | 0.87 | TAAR1 (0.42) | LIPGALOX15TSHRMEN1MAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 252 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-119463417-A | High-heat-conductivity epoxy resin composite material and preparation method thereof | 安徽邦德锐新材料科技有限公司 | 2025-02-18 | — | — | CN | claimed |
| CN-110204561-A | Organic solar batteries donor material and its application containing selenole and two indolocarbazoles | 江西师范大学 | 2019-09-06 | — | — | CN | claimed |
| CN-109824648-A | The aldehyde radical of the bromo- 3- dodecylthiophene of 2- | 山东高洁环保科技有限公司 | 2019-05-31 | — | — | CN | claimed |
| CN-109651600-A | A kind of preparation method of poly- 3- hexyl thiophene | 深圳烯湾科技有限公司 | 2019-04-19 | — | — | CN | claimed |
| CN-103483508-B | Preparation method of self-doped thiophene polymer | UNIV HEFEI TECHNOLOGY | 2015-07-15 | — | — | CN | claimed |
| CN-119463417-A | High-heat-conductivity epoxy resin composite material and preparation method thereof | 安徽邦德锐新材料科技有限公司 | 2025-02-18 | — | — | CN | disclosed |
| US-11828741-B2 | Sensor that detects an analyte in the presence of an interfering stimulus | THE JOHNS HOPKINS UNIVERSITY (US) | 2023-11-28 | — | — | US | disclosed |
| US-11773074-B2 | Method for aerobic oxidative coupling of thiophenes with a ligand-supported palladium catalyst | WISCONSIN ALUMNI RESEARCH FOUNDATION (US) | 2023-10-03 | — | — | US | disclosed |
| CN-116120527-A | Near-infrared conjugated polymer and preparation method and application thereof | 南京邮电大学 | 2023-05-16 | — | — | CN | disclosed |
| US-11567035-B2 | Ratiometric vapor sensor | THE JOHNS HOPKINS UNIVERSITY (US) | 2023-01-31 | — | — | US | disclosed |
| CN-113150253-B | Thiopyranone-based high-molecular compound and preparation method and application thereof | 中国科学院化学研究所 | 2022-08-16 | — | — | CN | disclosed |
| US-11370879-B2 | Solution-processable indenofluorenes and methods to generate solution-processable indenofluorenes | INTERNATIONAL BUSINESS MACHINES CORPORATION (US) | 2022-06-28 | — | — | US | disclosed |
| US-20030166829-A1 | Polythiophenes and devices thereof | XEROX CORPORATION | 2003-09-04 | — | — | US | disclosed |
| US-20030164495-A1 | Polythiophenes and devices thereof | XEROX CORPORATION | 2003-09-04 | — | — | US | disclosed |
| US-20030160234-A1 | Polythiophenes and devices thereof | XEROX CORPORATION | 2003-08-28 | — | — | US | disclosed |
| US-20030160230-A1 | Polythiophenes and electronic devices generated therefrom | XEROX CORPORATION | 2003-08-28 | — | — | US | disclosed |
| EP-1329475-A1 | Polythiophenes and devices thereof | Xerox Corporation (US) | 2003-07-23 | — | — | EP | disclosed |
| EP-1329476-A1 | Polythiophenes and devices thereof | Xerox Corporation (US) | 2003-07-23 | — | — | EP | disclosed |
| EP-1327647-A1 | Polythiophenes and devices thereof | Xerox Corporation (US) | 2003-07-16 | — | — | EP | disclosed |
| EP-1327646-A1 | Polythiophenes and devices thereof | Xerox Corporation (US) | 2003-07-16 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11370879-B2 | Solution-processable indenofluorenes and methods to generate solution-processable indenofluorenes | INF2, ABL1, ICMT | LIPG 3495/4885TP53 653/4885CYP3A4 159/4885 |
| US-11773074-B2 | Method for aerobic oxidative coupling of thiophenes with a ligand-supported palladium catalyst | PPOX, TST, COX6C | LIPG 2972/4885TP53 4382/4885CYP3A4 164/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.